Equities

Beijing Airdoc Technology Co Ltd

Beijing Airdoc Technology Co Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)12.66
  • Today's Change-0.32 / -2.47%
  • Shares traded60.80k
  • 1 Year change+27.88%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Beijing Airdoc Technology Co Ltd is a China-based company that provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company's main product is Airdoc-AIFUNDUS 1.0. The Company's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.

  • Revenue in HKD (TTM)220.19m
  • Net income in HKD-143.08m
  • Incorporated2015
  • Employees339.00
  • Location
    Beijing Airdoc Technology Co LtdRoom 21, 4th Floor, Building 2A2 Yard, West Third Ring North RoadHaidian DistrictBeijing 100000ChinaCHN
  • Phone+86 1 082362300
  • Websitehttps://www.airdoc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Guanze Medical Infrm Indstry (Hldng) Ltd168.49m29.76m760.00m56.0025.542.6120.754.510.03130.03130.17740.30620.48765.371.203,008,773.008.72--10.54--54.72--17.89--6.252,148.220.0748---11.88--53.63------
ClouDr Group Ltd3.98bn-348.77m968.61m1.52k--0.4488--0.2431-0.6447-0.64477.373.681.285.484.742,617,744.00-11.33---17.13--24.64---8.87--1.58-29.150.1314--23.51--80.87------
Ziyuanyuan Holdings Group Ltd537.58m15.72m1.22bn184.0072.003.3640.032.260.03930.03931.340.84330.81844.543.022,921,627.002.282.613.673.7124.69--2.786.131.752.340.31354.9653.4152.48-7.90-2.9897.56--
Beijing Airdoc Technology Co Ltd220.19m-143.08m1.31bn339.00--0.7885--5.95-1.38-1.382.1316.060.11912.262.84649,540.60-8.51---9.03--61.35---71.41--11.26--0.006--79.46--26.37------
Sisram Medical Ltd2.80bn245.89m1.41bn1.08k5.750.40063.840.50430.52480.52485.997.540.61471.804.392,597,016.005.635.946.706.8861.1057.669.1610.582.0013.960.086928.791.3618.48-21.597.6146.589.64
IVD Medical Holding Ltd3.33bn257.11m1.45bn803.004.680.33394.880.43390.19020.19022.472.670.67882.785.624,152,108.005.215.186.866.6721.7520.757.687.531.567.530.0923--12.3549.4913.4118.1519.77--
MicroTech Medical Hangzhou Co Ltd273.38m-134.96m1.50bn760.00--0.685--5.50-0.3171-0.31710.64225.230.11372.354.13359,707.80-5.62---5.85--49.13---49.37--21.22--0.00008--45.92---256.75------
Jenscare Scientific Co Ltd0.00-401.32m1.55bn376.00--1.17-----0.962-0.9620.003.190.00----0.00-27.49---28.61----------19.20--0.0347------15.38------
Gaush Meditech Ltd1.52bn187.33m1.66bn869.008.850.91356.171.091.271.2710.2612.260.50572.348.851,746,994.006.22--8.35--49.18--12.30--1.195.900.2814--12.16--149.63------
Peijia Medical Ltd476.23m-423.76m1.75bn1.04k--0.7139--3.68-0.624-0.6240.70113.610.14730.777337.52457,911.70-13.11-34.08-14.94-36.9073.7671.62-88.99-448.756.92--0.0886--75.86--3.75--106.68--
PW Medtech Group Ltd728.80m165.37m1.83bn1.24k11.080.41955.582.510.10560.10560.46552.790.13312.199.21585,854.604.047.234.918.0956.4258.1330.3785.3812.70--0.00024.1125.7516.7844.465.94-7.92--
MicroPort CardioFlow Medtech Corp362.97m-509.06m1.83bn592.00--0.7274--5.05-0.2154-0.21540.15361.040.12052.783.67613,123.30-16.91-17.37-18.11-22.962.06-1.67-140.25-180.829.91-11.560.0293--33.94---3.77---14.16--
Acotec Scientific Holdings Ltd511.55m15.64m1.96bn638.00120.541.4029.963.840.0520.0521.704.470.31360.72133.44801,808.800.9589--1.03--79.65--3.06--9.122.750.1529--19.80---79.35------
Data as of Jul 26 2024. Currency figures normalised to Beijing Airdoc Technology Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

17.21%Per cent of shares held by top holders
HolderShares% Held
Lake Bleu Capital (Hong Kong) Ltd.as of 05 Jun 20244.79m8.96%
China Life Insurance (Overseas) Co., Ltd.as of 29 Nov 20232.64m4.95%
UBS Asset Management Switzerland AGas of 21 Apr 20231.29m2.41%
GF Fund Management Co., Ltd.as of 31 Dec 2023475.50k0.89%
China Universal Asset Management Co., Ltd.as of 31 Dec 20231.00k0.00%
More ▼
Data from 29 Nov 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.